NL-OMON27791尚未招募不适用
Implementation of pharmacokinetic-guided dosing of prophylaxis in hemophilia patients
Erasmus Medical Center, Sophia Children's Hospital0 个研究点目标入组 50 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Hemophilia A and B patients of all ages on prophylaxis;
- •-Prophylaxis with SHL factor concentrates or EHL factor concentrates;
排除标准
- •-Patients with other congenital or acquired hemostatic abnormalities;
- •-General medical conditions which may interfere with participation in the study;
研究者
相似试验
进行中（未招募）
1 期
Implementation of pharmacokinetic-guided dosing of prophylaxis in hemophilia patients.MedDRA version: 20.0 Level: LLT Classification code 10060614 Term: Hemophilia B (Factor IX) System Organ Class: 100000004850MedDRA version: 20.0 Level: LLT Classification code 10060613 Term: Hemophilia A (Factor VIII) System Organ Class: 100000004850HemophiliaEUCTR2018-003869-33-NLErasmus University Medical Center50
尚未招募
不适用
Implementation of pharmacokinetic-guided dosing of prophylaxis in hemophilia patients.hemophiliaNL-OMON55874Erasmus MC, Universitair Medisch Centrum Rotterdam50
招募中
不适用
Implementation of pharmacokinetic-guided dosing of DDAVP and VWF-containing concentrates in von Willebrand diseaseNL-OMON54546Erasmus MC, Universitair Medisch Centrum Rotterdam160
进行中（未招募）
1 期
Effects of pharmacokinetic models in dosing of DDAVP and/or von Willebrand factor-containing concentrates in patients with von Willebrand diseaseVon Willebrand diseaseMedDRA version: 20.0Level: LLTClassification code 10055168Term: Von Willebrand's factor deficiencySystem Organ Class: 100000004850EUCTR2018-001631-46-NLErasmus University Medical Center120
已完成
不适用
Development of a method for better estimation of warfarin dose in patients requiring warfarin therapyCTRI/2018/06/014614Dr Nusrat Shafiq82